This Best Practices Report intends to bring our experience in European Industrial Doctorates (EID) to other consortia with awarded EID Programmes ongoing and to institutions considering applying for funding to this scheme.
The fellows presented their first year scientific results at the GSK DDW site
Gordon Conference on Tuberculosis Drug Development
conference featured a discussion of target and compound discovery,
new potential antituberculosis compounds which are in development,
clinical trial design and early trial results, and alternative
approaches to tuberculosis treatment.
Dr. David Barros, TB Drug
Discovery Director at GSK DDW, was appointed Vice-chairman and
Chairman for the 2013 and 2015 Conferences, respectively. More
information on the Conference's website
left to right: Maciej Rogacki, Robert
Bates, Eleni Pitta, Lluís Ballell,
Pieter Van der Veken, Olga Balabon and David